|
Neoplasia
Citations 61-70 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma
- Katherine R. Calvo, Bhavana Dabir, Alexandra Kovach, Christopher Devor, Russell Bandle, Amelia Bond, Joanna H. Shih, and Elaine S. Jaffe
Blood 2008; 112: 3818-3826.
[Abstract]
[Full text]
[PDF]
p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism
- Andrew J. Steele, Archibald G. Prentice, A. Victor Hoffbrand, Birunthini C. Yogashangary, Stephen M. Hart, Elisabeth P. Nacheva, Julie D. Howard-Reeves, Veronique M. Duke, Panagiotis D. Kottaridis, Kate Cwynarski, Lyubomir T. Vassilev, and R. Gitendra Wickremasinghe
Blood 2008; 112: 3827-3834.
[Abstract]
[Full text]
[PDF]
Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib
- Feng-Ting Liu, Samir G. Agrawal, Zanyar Movasaghi, Peter B. Wyatt, Ihtesham U. Rehman, John G. Gribben, Adrian C. Newland, and Li Jia
Blood 2008; 112: 3835-3846.
[Abstract]
[Full text]
[PDF]
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance
- Ilaria Iacobucci, Annalisa Lonetti, Francesca Messa, Daniela Cilloni, Francesca Arruga, Emanuela Ottaviani, Stefania Paolini, Cristina Papayannidis, Pier Paolo Piccaluga, Panagiota Giannoulia, Simona Soverini, Marilina Amabile, Angela Poerio, Giuseppe Saglio, Fabrizio Pane, Giorgio Berton, Anna Baruzzi, Antonella Vitale, Sabina Chiaretti, Giovanni Perini, Robin Foà, Michele Baccarani, and Giovanni Martinelli
Blood 2008; 112: 3847-3855.
[Abstract]
[Full text]
[PDF]
Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73
- Masahiro Kawahara, Toshiyuki Hori, Kazuhisa Chonabayashi, Tsutomu Oka, Marius Sudol, and Takashi Uchiyama
Blood 2008; 112: 3856-3866.
[Abstract]
[Full text]
[PDF]
Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence
- Jean-Jacques Lataillade, Olivier Pierre-Louis, Hans Carl Hasselbalch, Georges Uzan, Claude Jasmin, Marie-Claire Martyré, and Marie-Caroline Le Bousse-Kerdilès, on behalf of the French INSERM and the European EUMNET Networks on Myelofibrosis
Blood 2008; 112: 3026-3035.
[Abstract]
[Full text]
[PDF]
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia patients: a population-based study in Sweden
- Sigurdur Y. Kristinsson, Magnus Björkholm, Lynn R. Goldin, Mary L. McMaster, Ingemar Turesson, and Ola Landgren
Blood 2008; 112: 3052-3056.
[Abstract]
[Full text]
[PDF]
Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring
- Ye-Xiong Li, Hui Fang, Qing-Feng Liu, Jiade Lu, Shu-Nan Qi, Hua Wang, Jing Jin, Wei-Hu Wang, Yue-Ping Liu, Yong-Wen Song, Shu-Lian Wang, Xin-Fan Liu, Xiao-Li Feng, and Zi-Hao Yu
Blood 2008; 112: 3057-3064.
[Abstract]
[Full text]
[PDF]
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- Jean-Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Bernard Grandchamp, Christine Chomienne, and Pierre Fenaux
Blood 2008; 112: 3065-3072.
[Abstract]
[Full text]
[PDF]
Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation
- Suzanne O. Arulogun, H. Miles Prince, Jonathan Ng, Stephen Lade, Gail F. Ryan, Odette Blewitt, and Christopher McCormack
Blood 2008; 112: 3082-3087.
[Abstract]
[Full text]
[PDF]
|
|
